Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2016; 6(5): 119-123


A Study on the Adverse Drug Reactions Induced by Anti Epileptic Drugs in the Epileptic Patients

Keerthy Jayalekshmi, Kavitha Palanisamy, Sambathkumar Ramanathan, Sruthi Akela.




Abstract

A research work carried for six months on epileptic patients, from April 2014 to September 2014, in a tertiary teaching care hospital, Erode. 180 epilepsy patients of both gender and all age groups undergoing treatment with only anti epileptic drugs (AEDs) were monitored for adverse drug reactions (ADRs). The drug regimen, type of seizure, gender and age group of patients were analyzed. The demographic details, case details, laboratory blood analysis, liver function tests and electrolyte profile values were collected in data entry forms.With the help of physician and previous studies, conclusions were drawn. The identified ADRs were entered in the ADR form and the causality assessment of ADRs was done using Naranjo’s scale . Monotherapy was preferred in majority of subjects. Conventiional AEDs were found to be highly utilised compared to novel drugs. Sodium valproate, Carbamazepine and Phenytoin was found induce more number of ADRs. Statistical analysis using graph pad prism version 6 was done.

Key words: Epilepsy, anti epileptic drug, adverse drug reactions.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.